Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
55.74
+3.22 (6.13%)
At close: Mar 9, 2026, 4:00 PM EDT
55.51
-0.23 (-0.41%)
Pre-market: Mar 10, 2026, 4:12 AM EDT
Moderna Revenue by Segment
History
| Date | Product Sales | Grant and Collaboration |
|---|---|---|
| Dec 31, 2025 | 1.82B | 126.00M |
| Sep 30, 2025 | 2.11B | 121.00M |
| Jun 30, 2025 | 2.96B | 120.00M |
| Mar 31, 2025 | 3.03B | 149.00M |
| Dec 31, 2024 | 3.11B | 145.00M |
| Sep 30, 2024 | 4.96B | 191.00M |
| Jun 30, 2024 | 4.90B | 200.00M |
| Mar 31, 2024 | 5.01B | 177.00M |
| Dec 31, 2023 | 6.67B | 384.00M |
| Sep 30, 2023 | 8.77B | 554.00M |
| Jun 30, 2023 | 10.14B | 721.00M |
| Mar 31, 2023 | 14.37B | 828.00M |
| Dec 31, 2022 | 18.47B | 879.00M |
| Sep 30, 2022 | 20.51B | 794.00M |
| Jun 30, 2022 | 22.20B | 733.00M |
| Mar 31, 2022 | 21.87B | 796.00M |
| Dec 31, 2021 | 17.68B | 890.22M |
| Sep 30, 2021 | 10.94B | 889.13M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.